Navigation Links
Clarient Launches Insight® Dx Mammostrat® Breast Cancer Recurrence Test
Date:12/9/2010

nt's principal customers include pathologists, oncologists, hospitals, and biopharmaceutical companies.  The rise of individualized medicine as the new direction in oncology has created the need for a centralized resource providing leading diagnostic technologies, such as flow cytometry and molecular testing.  Clarient is that resource, having created a state-of-the-art commercial cancer laboratory providing the most advanced oncology testing and diagnostic services.  Clarient's customers are connected to its Internet-based portal, PATHSiTE® that delivers high resolution images and critical interpretive reports based on our diagnostic testing.  Clarient also develops and markets new, proprietary "companion" diagnostic markers for therapeutics in breast, prostate, lung, ovarian, and colon cancers, and leukemia/lymphoma. www.clarientinc.com

Forward Looking StatementsCertain statements herein regarding Clarient, Inc. contain forward-looking statements that involve risks and uncertainty. Future events and Clarient's actual results could differ materially from the results reflected in these forward-looking statements. Factors that might cause such a difference include, but are not limited to: Clarient's ability to continue to develop and expand its diagnostic services business, uncertainties inherent in Clarient's product development programs, Clarient's ability to attract and retain highly qualified managerial, technical, and sales and marketing personnel, Clarient's ability to maintain compliance with financial and other covenants under its credit facility, Clarient's ability to successfully manage its in-house billing and collections processes, the continuation of favorable third-party payor reimbursement for laboratory tests, changes in federal payor regulations or policies, including adjustments to Medicare reimbursement rates, that may affect coverage and reimbursement for Clarient's la
'/>"/>

SOURCE Clarient, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GE Healthcare to Acquire Cancer Diagnostic Company Clarient Inc.
2. Clarient Acquires Applied Genomics, Inc.
3. Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer
4. Clarient Announces CFO Transition Plan
5. Clarient to Present at Upcoming Healthcare Investor Conferences in New York City
6. CareFusion Launches Respiratory Airway Adapter to Improve Patient Safety and Reduce Hospital Costs
7. UBM TechInsights Launches Product Teardowns for Medical Electronics
8. Purdue Pharma L.P. Re-launches Partners Against Pain Website
9. CareFusion Launches Next-Generation Clinical Pulmonary and Cardiopulmonary Diagnostics Software
10. BugLab Launches Worlds First Handheld Non-invasive Optical Density Sensor
11. The Citizen CPR Foundation Launches National Call to Action to Empower Citizens to Save Lives of Those with Sudden Cardiac Arrest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 Rolta gab ... Sadara Chemical Company (Sadara) erhalten zu haben, ... des integrierten Chemiekomplexes von Sadara in Jubail ... im Wert von mehreren Millionen Dollar stellt ... dessen Wert sich ebenfalls auf mehrere Millionen ...
(Date:7/22/2014)...  Nektar Therapeutics (Nasdaq: NKTR ) will announce ... 2014 on Thursday, July 31, 2014, after the close of ... executive officer, will host a conference call to review the ... Time (PT). The press release and a ... through a link that is posted on the home page ...
(Date:7/22/2014)... 22, 2014  Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, announced that Edwards, Chairman ... as an expert panelist at the invitation of the ... to discuss medical device innovation at its hearing, "21 ... Development and Communication." "Edwards has five decades ...
Breaking Medicine Technology:Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 2Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 3Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 4Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2
... N.C. , July 21 /PRNewswire-FirstCall / -- SPX ... completed the acquisition of the Anhydro business, a Soeborg, Denmark ... dewatering plants and equipment.  The terms of the transaction were not ... Anhydro ...
... DETROIT , July 21 Caraco Pharmaceutical ... shipping bupropion hydrochloride extended release tablets. This product was ... (FDA) for Sun Pharma,s Abbreviated New Drug Application (ANDA). ... mg, and 200 mg, are therapeutically equivalent to GlaxoSmithKline,s ...
Cached Medicine Technology:SPX Completes Acquisition of Anhydro 2SPX Completes Acquisition of Anhydro 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Wellbutrin SR® Extended Release Tablets 2
(Date:7/23/2014)... July 23, 2014 QueenBeeTickets.com is reducing the ... a coup for rock music fans who are still in ... buyers visit the site, they can use promo code “DISCOUNT” ... Here to view the inventory of discounted tickets at ... in August, September and October, with The Eagles concert tickets ...
(Date:7/23/2014)... Temecula Valley Southern California Wine Country, ... Wine Country artisan food and wine experiences combine ... nourishing. Savor like locals at Briar Rose, Cougar, ... EAT Marketplace, Palumbo’s Ristorante, Robin’s Nest, Old Town ... Kimberly Adams, president and CEO, Visit Temecula Valley ...
(Date:7/23/2014)... In an effort to help advance ... Disease” at the state level, the National Alliance ... of America (AFA) this week released a white ... and the need for wide-scale implementation of state plans ... The white paper outlines recommendations for both ...
(Date:7/23/2014)... living with multiple chronic medical conditions, a new study ... Health finds that the more ailments you have after ... one of the first to examine the burden of ... may help explain why increases in life expectancy among ... findings, based on an analysis of 1.4 million Medicare ...
(Date:7/22/2014)... July 23, 2014 Recently, iFitDress.com, a popular ... has announced its new selection of white party dresses ... that custom made outfits are now available on its website. ... before the end of July can get a discounted rate, ... products are popular among international customers, so its marketing specialist ...
Breaking Medicine News(10 mins):Health News:History of The Eagles Tour Tickets: QueenBeeTickets.com Reduces Prices on Remaining Inventory of Concert Tickets for 2014 Shows 2Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 2Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 3Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 4Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 2Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 3Health News:Life expectancy gains threatened as more older Americans suffer from multiple conditions 2Health News:Life expectancy gains threatened as more older Americans suffer from multiple conditions 3Health News:Elegant White Party Dresses Now Provided by Distinguished Company iFitDress.com 2
... of the AMA,board, HONOLULU, Hawaii, Nov. 13 ... Inc., has been newly elected,to the American Medical Association ... today. Mr. Kay will be the,only non-physician member on ... the position., Mr. Kay has spent his career ...
... Nov. 13 Nastech,Pharmaceutical Company Inc. ("Nastech") (Nasdaq: ... Directors has approved the recommendation of its Special,Committee ... Nastech,s,wholly-owned subsidiary, MDRNA, Inc. ("MDRNA"), as an independent ... related to,RNA interference ("RNAi") into MDRNA. The new ...
... BOTHELL, Wash., Nov. 13 Nastech,Pharmaceutical Company ... its,corporate restructuring initiatives aimed at reducing operating expenses,and ... its,subsidiary, MDRNA, Inc., as an independent, separately financed ... Phase 2 clinical and partnered,programs as well as ...
... (SWX:,ROG.VX; RO.S) confirmed today that it has entered into ... VMSI ) and that it,will commence due diligence. Roche ... with respect to the acquisition of Ventana will be,reached. ... offer to acquire all of the,outstanding common shares of ...
... of sound in medicine has a long history. Doctors have ... human body since the early 19th century, and ultrasound imaging ... the United States typically know the gender of their offspring ... pregnancy. , Now scientists are finding many more advanced applications ...
... A gene linked to pediatric brain tumors is an essential ... of Medicine in St. Louis have found. , The study, ... neurofibromatosis 1 (NF1) gene helps push stem cells down separate ... brain cells: support cells known as astrocytes and brain neurons. ...
Cached Medicine News:Health News:Fortune 500 Executive Elected to AMA Board of Trustees 2Health News:Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics 2Health News:Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics 3Health News:Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics 4Health News:Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 2Health News:Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 3Health News:Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 4Health News:Roche Confirms Commencement of Due Diligence with Ventana 2Health News:Roche Confirms Commencement of Due Diligence with Ventana 3Health News:Roche Confirms Commencement of Due Diligence with Ventana 4Health News:Sound medicine at Acoustics Meeting 2Health News:Sound medicine at Acoustics Meeting 3Health News:Sound medicine at Acoustics Meeting 4Health News:Sound medicine at Acoustics Meeting 5Health News:Sound medicine at Acoustics Meeting 6Health News:Sound medicine at Acoustics Meeting 7Health News:Sound medicine at Acoustics Meeting 8Health News:Cancer gene drives pivotal decision in early brain development 2Health News:Cancer gene drives pivotal decision in early brain development 3
Fulgurating Electrode, 3 F...
... Flexible CystoNephroscope is used for percutaneous and ... practice. The large 6.4 Fr (2.1 mm) ... operating instruments for therapeutic applications. The flexible ... covered tip provide fast, less traumatic access ...
Inquire...
Used to obtain tissue biopsy under direct vision. Cup Biopsy Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: